Metformin Hydrochloride
Metformin Hydrochloride is widely regarded as the first-line medication for the treatment of Type 2 Diabetes. It belongs to the biguanide class of drugs and works primarily by reducing the amount of glucose produced by the liver.
In addition to suppressing hepatic glucose production, it increases the sensitivity of muscle cells to insulin, allowing the body to use its existing insulin more effectively. Clinical benefits include:
Weight Neutrality: Unlike many other diabetes medications, it does not typically cause weight gain.
Cardiovascular Protection: Studies suggest it may reduce the risk of heart-related complications in diabetic patients.
Low Hypoglycemia Risk: It rarely causes dangerously low blood sugar when used as a monotherapy.
Common side effects are gastrointestinal in nature, though these are often mitigated by using extended-release (ER) formulations that release the drug slowly throughout the day.